Literature DB >> 22288970

Progressive granulomatous pneumonitis in response to cosmetic subcutaneous silicone injections in a patient with HIV-1 infection: case report and review of the literature.

Lida P Hariri1, Henning A Gaissert, Robert Brown, Andrea Ciaranello, Reginald E Greene, Martin K Selig, Richard L Kradin.   

Abstract

Silicone, commonly used in cosmetic procedures owing to its presumed inertness, can yield serious sequelae including acute embolization and pneumonitis. Chronic pulmonary sequelae in response to silicone injection have not been previously described. We report a case of chronic progressive granulomatous pneumonitis in response to subcutaneous silicone injections in a transgender male-to-female patient infected with human immunodeficiency virus 1 (HIV-1). After receiving silicone injections to the buttock, the patient developed rapid onset dyspnea, pleuritic chest pain, fever, and chills. Chest computed tomography revealed diffuse peripheral interstitial opacities. She responded symptomatically to prednisone with subsequent intermittent symptomatic flares. Four years later, she developed marked dyspnea and cough. Chest computed tomography showed progressive diffuse ground-glass and nodular opacities. Lung biopsies demonstrated numerous spheroid silicone particles within the lung interstitium and small pulmonary vessels, surrounded by foreign body giant cells and nonnecrotizing granulomatous inflammation. We speculate that HIV-1-infected patients may be at risk for chronic, progressive granulomatous pneumonitis due to silicone injection years after their procedure owing to shifting levels of cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22288970     DOI: 10.5858/arpa.2011-0149-CR

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

1.  [Side effects in aesthetic medicine. Spectrum, management and avoidance].

Authors:  U Wollina; A Goldman; C Naoum
Journal:  Hautarzt       Date:  2013-03       Impact factor: 0.751

Review 2.  HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action.

Authors:  Tonia Poteat; Mannat Malik; Ayden Scheim; Ayana Elliott
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

3.  The use and correlates of illicit silicone or "fillers" in a population-based sample of transwomen, San Francisco, 2013.

Authors:  Erin Wilson; Jenna Rapues; Harry Jin; Henry Fisher Raymond
Journal:  J Sex Med       Date:  2014-05-09       Impact factor: 3.802

4.  Pulmonary Empty Spaces: Silicone Embolism-A Decade of Increased Incidence and Its Histological Diagnosis.

Authors:  Kirill Lyapichev; Felix Manuel Chinea; Julio Poveda; Jeniffer Pereda; Pablo A Bejarano; Monica T Garcia-Buitrago
Journal:  Case Rep Pathol       Date:  2016-01-27

5.  Interstitial lung diseases associated with metal content in silicone breast implants: a case series.

Authors:  Elizabeth Fireman; Dror Rosengarten; Einat Zelinger; Mordechai R Kramer
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

6.  Psychosocial Differences Between Transgender Individuals With and Without History of Nonsurgical Facial Injectables.

Authors:  Patrick J Kelly; Anne S Frankel; Paul D'Avanzo; Katie Suppes; Adrian Shanker; David B Sarwer
Journal:  Aesthet Surg J Open Forum       Date:  2020-11-10

7.  Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report.

Authors:  Mersad Alimoradi; Ahmad Chahal; Elie El-Rassi; Karim Daher; Gazy Sakr
Journal:  Ann Med Surg (Lond)       Date:  2021-09-03

8.  Filler Use Among Trans Women: Correlates of Feminizing Subcutaneous Injections and Their Health Consequences.

Authors:  Francesco D Sergi; Erin C Wilson
Journal:  Transgend Health       Date:  2021-04-15

9.  Recurrent Silicone Embolism Syndrome requiring VA ECMO.

Authors:  Nikhil Madan; Umair Khan; Anthony Martins; Gabriela Andries; John Matthews; Vipul Patel; Gautam Visveswaran
Journal:  Respir Med Case Rep       Date:  2022-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.